It offers once-daily dosing, versus twice-daily with BMS' drug and, according to some assessments, could be less prone to cause GI side effects. Other therapies hoping to provide a new way to ...

Lynch will leave the company by 1 October, to “pursue opportunities in healthcare,” according to BMS’ statement on the new appointments. On the commercial side, Celgene’s chief financial ...

According to DelveInsight's analysis, the market for GIST is anticipated to increase during the forecast period (2025–2034), owing to the launch of e ...

The growth in Bad Birdie’s women’s line is a reflection of the growing popularity of women’s golf.

Have top stories from The Daily Pennsylvanian delivered to your inbox every day, Monday through Friday, when Penn classes are in session.